7 April 2025 in Clinical Dentistry (Russia)
Lichen planus is a chronic autoimmune skin-mucosal disease that often affects the oral cavity and can affect the esophagus, the mucous membrane of the genitals, the skin and its appendages. Lichenoid reactions are considered as lesions clinically similar to lichen planus erythematosus, but differing in pathogenesis, etiology and, consequently, treatment approaches. The main provoking factors of lichenoid reactions are medicines and dental materials. The aim of the study was to identify histopathological differences between lichen planus erythematosus and lichenoid reactions of the oral cavity for a more accurate differential diagnosis of these conditions. Materials and methods. The study included 35 patients of both sexes, aged 35 to 70 years, who sought treatment between 2019 and 2024. All patients were clinically diagnosed with lichen planus of the oral mucosa (L43) or lichenoid reaction of the oral mucosa (L43.8 according to ICD-10). Among them were 10 patients with erosive and ulcerative form, 12 patients with hyperkeratotic form of Lichen planus, 8 patients with exudative-hyperemic form of Lichen planus and 5 patients with lichenoid reactions in the oral cavity. All patients underwent an incision biopsy of the affected areas of the oral mucosa, followed by histopathological analysis. Results. Despite the similarity of clinical and histopathological signs of lichen planus and lichenoid reactions, the study revealed signs that allow them to differentiate. The presence of Sivatt bodies, hydropic degeneration and banded lymphocytic infiltrate are key diagnostic signs of lichen planus. Conclusions. Histological analysis of biopsy material should be considered as the main research method for making a final diagnosis when detecting lesions of the oral mucosa.
21 September 2023 in Russian Journal of Operative Surgery and Clinical Anatomy
ОБОСНОВАНИЕ Красный плоский лишай слизистой оболочки полости рта (КПЛ СОПР) — хроническое воспалительное заболевание, поражающее слизистую оболочку полости рта. Это распространенное заболевание, которым страдает около 1—2% населения во всем мире. Хотя КПЛ СОПР обычно не считается злокачественным заболеванием, но среди медицинских работников и пациентов растет беспокойство по поводу его способности трансформироваться в рак полости рта. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка потенциала злокачественной трансформации КПЛ СОПР в период с 2012 по 2022 г., изучение факторов риска злокачественной трансформации КПЛ СОПР, анализ форм КПЛ, переродившихся в рак. МАТЕРИАЛ И МЕТОДЫ Проведена клиническая оценка базы данных пациентов из отделения хирургической стоматологии и имплантологии ГБУЗ МО МОНИКИ им. М.Ф. Владимирского в период с 2012 по 2022 г. с диагнозом КПЛ СОПР. Клинические данные, включая демографические характеристики пациентов, клиническую картину, гистопатологические особенности и тактику ведения, были собраны из историй болезни пациентов. Срок наблюдения составил 10 лет. Для оценки различий показателей применен критерий Манна—Уитни (непараметрический аналог критерия t Стьюдента в случае сравнения двух независимых групп). Критический уровень значимости при проверке нулевой статистической гипотезы принимали равным 0,05. РЕЗУЛЬТАТЫ Всего в исследование включены 154 пациента с диагнозом КПЛ СОПР. За период наблюдения у 12 (8%) пациентов развилась злокачественная трансформация в течение десятилетнего периода наблюдения. Среднее время до злокачественной трансформации составило 5,2 года (от 1 до 9 лет). Наиболее частым местом злокачественной трансформации был язык (50%), за ним следовала слизистая оболочка щек (25%) и другие участки (25%). ЗАКЛЮЧЕНИЕ Пациенты с длительно текущими эрозивно-язвенными формами КПЛ СОПР должны быть под тщательным наблюдением специалистов.
20 February 2024 in Russian Journal of Operative Surgery and Clinical Anatomy
Background. Red lichen planus of the oral mucosa is a chronic inflammatory disease affecting the oral mucosa. Lichen planus of the oral cavity (CPL) and hyposalivation are among the extrahepatic manifestations associated with hepatitis C virus (HCV) infection. Patients with chronic hepatitis C often suffer from these oral diseases, which can significantly affect their quality of life. This is a common disease that affects about 1—2% of the world’s population. Objective. The aim of the study was to evaluate the effectiveness of direct antiviral agents in the treatment of CPL and hyposalivation in patients with chronic hepatitis C. Material and methods. A total of 215 patients were tested for HCV antibodies. The study included a comprehensive examination of patients before, during and after the use of antiviral drugs. Patients with a positive test result underwent quantitative HCV RNA testing and HCV genotype typing. In addition, the patients underwent oral examination using the CPL score system (REU scale) and the clinical Oral Dryness Scale (CODS). Subsequently, all eligible patients received antiviral therapy using glecaprevir /pibrentasvir (Maviret), and the condition of their oral cavity was systematically assessed 1, 3 and 6 months after the start of treatment. Results. Of the 215 patients who underwent the examination, 17 patients (7.9%) tested positive for HCV RNA. At the initial assessment, CPL was diagnosed in 4 patients (1.86%) with an average REU score of 10.13±4. In addition, 7 patients (3.26%) had hyposalivation of varying degrees with an average CODS score of 4.71±1.72. Six months after the start of therapy, there was a noticeable improvement in the condition of the oral cavity of patients. In particular, CPL was resolved in 3 out of 4 affected patients (75%), and the remaining patient had a significant decrease in the average REU score (2±4). Hyposalivation completely disappeared in 3 patients, improved in 2 patients and remained unchanged in 2 people. The average CODS score decreased significantly to 0.06±0.24 in patients with hyposalivation. The results highlight the potential benefits of antiviral drugs, in addition to their main role in eradicating HCV infection, and emphasize their value in eliminating concomitant extrahepatic manifestations, which ultimately improves the overall well-being of patients. Conclusion. The results of this study emphasize the importance of regular screening of oral lesions in the examination of HCV-positive patients and have demonstrated a marked improvement in the indicators of CPL and hyposalivation among patients with HCV infection after therapy with direct-acting antiviral drugs.